Document |
Document Title |
WO/1994/027976A1 |
A triazole derivative represented by general formula (1) or a salt thereof, and a fungicide containing the same, wherein R1 and R2 represent each methyl, or R1 and R2 are combined together to represent ethylene. The compound (1) has a hi...
|
WO/1994/026700A1 |
Compounds of formula (I) in which Y is hydrogen, C1-C4alkyl, C1-C4alkoxy, OH, CN, NO2, Si(CH3)3, CF3 or halogen, Z is a group (a) or (b) and R1 is hydrogen, C1-C4alkyl, C2-C4alkenyl, C2-C4-alkynyl, C3-C6cycloalkyl, phenyl which is unsubs...
|
WO/1994/026734A1 |
An antifungal agent containing as the active ingredient a compound represented by general formula (I) or an acid-addition salt thereof, in particular, one having an absolute configuration of (R, R) at the asymmetric carbon atoms or an ac...
|
WO/1994/026737A1 |
An imidazolylquinoxalinedione derivative, represented by general formula (I), useful as a glutamate receptor antagonist, a pharmaceutically acceptable salt thereof, and a pharmaceutical composition containing the same as the active ingre...
|
WO/1994/026709A1 |
Guanidine derivatives of formula (I), wherein Y is N or C-R1 (in which R1 is hydrogen, lower alkyl, hydroxy, protected hydroxy, etc.), R2 is hydrogen, aryl which may have one suitable substituent, aryloxy, etc., R3 is hydrogen, lower alk...
|
WO/1994/025452A1 |
Disclosed is a process for preparing chiral compounds of formula (I) wherein: X1 and X2 are independently F or Cl; and E is -SO2R2, wherein R2 is C1-C6 alkyl, -C6H4CH3 or -CF3; its enantiomer and racemates thereof, useful in the synthesi...
|
WO/1994/025665A1 |
A process for dyeing or printing organic material, preferably fibre material, which comprises applying dyes together with a colourless cationic compound containing at least two polymerisable double bonds, as well as additional optional a...
|
WO/1994/025469A1 |
Described are compounds of formula (I) in which R1, R5, R6, R7 and R8 are as defined in the application, plus their preparation and their use in drugs.
|
WO/1994/024868A1 |
The invention concerns the use, as insecticides, nematicides and acaricides, of 2-dichloromethyl-1,3,4-oxydiazoles, some of them prior art compounds, of general formula (I) in which X is a single bond or one of the following groups: -O-,...
|
WO/1994/024305A1 |
Method of preparing an optically active compound of formula (I), wherein R and R1 are independently alkyl, alkenyl, alkynyl, alkoxy, alkoxyalkyl, cycloalkyl, aryl, aralkyl, a heterocyclic group or a C1-C4 alkyl-heterocycle, each being op...
|
WO/1994/023577A1 |
Triazolyl and tetrazolyl phenyl substituted carbapenems of formula (I) are disclosed. One or two of the variables X, Y and Z represent nitrogen atoms. The heteroaryl ring may be charged or uncharged. Pharmaceutical compositions and metho...
|
WO/1994/022812A1 |
Described are compounds of the formula (I) in which Y is oxygen or an NR6 group; Z1 and Z2 are hydrogen, halogen, alkyl, alkenyl, alkinyl, alkoxy, alkenyloxy, haloalkyl, haloalkoxy, haloalkenyloxy, cyano or nitro; R1 is hydrogen, alkyl, ...
|
WO/1994/022413A2 |
The invention relates to pharmaceutical compositions for the treatment or prevention of lesions of gastrointestinal mucous membranes and having secretion inhibiting, cytoprotective activities. The compositions contain in a biologically e...
|
WO/1994/022852A1 |
Optionally 6,8-substituted quinolines of formula (I) wherein: R1 is selected from hydrogen; lower alkyl; cycloalkyl; cycloalkyloxy; cycloalkylamino; cycloalkyl lower alkyl; lower alkoxy; formyl; hydroxy-lower alkyl; carboxyalkyl; optiona...
|
WO/1994/022855A1 |
The present invention relates to a nitrogen-containing heterocyclic compound exhibiting an inhibitory activity against cGMP-PDE. The compound represented by formula (I) or a pharmacologically acceptable salt thereof, wherein R1 represent...
|
WO/1994/022826A1 |
The present invention relates to novel peripheral vasodilating agents characterized by each containing as an active ingredient, a piperidine derivative or pharmaceutically acceptable salt thereof having excellent peripheral vasodilating ...
|
WO/1994/022835A2 |
A compound of the general formula (I): (M1)n-Q-(M2)1-n-L-A wherein: n is 0 or 1; M1 is an amino group; Q is an aromatic heterocyclic group containing a basic nitrogen atom; M2 is an imino group; L is a template group; and A is an acidic ...
|
WO/1994/022842A1 |
This invention relates to 1-amino-3-phenoxy-propane-derivatives of formula (1) (in which A, B, R, Rx, X and Z are defined as in the specification described) and methods for their preparation. These compounds may be used as modulators of ...
|
WO/1994/021606A1 |
Compounds with insecticidal or acaricidal activity have formula (IA) or (IB), wherein Ra represents hydrogen or from 1 to 4 optional substituents and Rb represents from 1 to 3 optional substituents and wherein A represents an optionally ...
|
WO/1994/019346A1 |
Compounds having the formula (I), in which R1, R2, R3, R4, R5, R6, R7, m, n and p have the meanings given in the description, are suitable for controlling helicobacter bacteria.
|
WO/1994/019321A1 |
Novel indole compounds inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts, pharmaceutical composition ing...
|
WO/1994/019329A1 |
This invention relates to substituted cyclic carbonyls and derivatives thereof useful as Human Immnunodeficiency Virus (HIV) protease inhibitors, to pharmaceutical compositions comprising such compounds, and to methods of using these com...
|
WO/1994/018174A1 |
The present invention pertains to new substituted tetrahydropyridazine carboxamides of general formula (I), in which R1 stands for hydrogen or alkyl, R2 stands for alkyl carbonyl or alkoxy carbonyl or R1 and R2 together with the nitrogen...
|
WO/1994/018177A1 |
The invention relates to novel arylaminosulphonyl ureas of the general formula (I) in which R1 is possibly substituted alkyl with 2 to 10 carbon atoms, aryl or aralkyl, R2 is hydrogen, hydroxy, cyano, alkoxycarbonyl or possibly substitut...
|
WO/1994/018176A1 |
The invention relates to novel arylaminosulphonyl ureas of the general formula (I) in which n represents the figures 1 or 2, R1 is possibly substituted alkyl, aryl or aralkyl, R2 is hydrogen, hydroxy, cyano, alkoxycarbonyl or possibly su...
|
WO/1994/014793A1 |
The present invention relates to cyclic sulfone moiety-containing hydroxyethylamine protease inhibitor compounds and pharmaceutical or method of use therefor, particularly as an inhibitor of HIV protease.
|
WO/1994/014767A1 |
Compounds of formula (I), or a salt or prodrug thereof are tachykinin antagonists.
|
WO/1994/014436A1 |
A retroviral protease inhibiting compound of formula (A) is disclosed.
|
WO/1994/014761A1 |
A compound having general formula (I), wherein R1 and R2 are independently hydrogen, C1-4 alkyl, C1-4 haloalkyl, C2-4 alkenyl, C2-4 alkynyl, C3-6 cycloalkyl, aryl or aryl(C1-4)alkyl; R3 is hydrogen, C1-4 alkyl, C1-4 haloalkyl or C3-6 cyc...
|
WO/1994/014742A1 |
Compounds of general formula (1) are described wherein Y is a halogen atom or a group -OR1, where R1 is an optionally substituted alkyl group; X is -O-, -S- or -N(R8)-, where R8 is a hydrogen atom or an alkyl group; R2 is an optionally s...
|
WO/1994/013712A1 |
The monomer is characterized by the general formula (1) [(R1)(R2)C = C(R3)-CO-L-]q A(NCObloc)p wherein R1, R2 and R3 similar or different, represent a hydrogen or a group selected among the hydrocarbon chains having from 1 to 12 carbon a...
|
WO/1994/013645A1 |
New compounds of formula (I) wherein R1 is H, CH3, OCH3, NO2, NH2, CN, CF3, CHF2, CH2F or halogen, R2 is a heterocyclyl radical selected from 1-imidazolyl, triazolyl, tetrazolyl, pyrazolyl, pyrimidinyl, oxazolyl, thiazolyl, isoxazolyl an...
|
WO/1994/013652A1 |
A compound of formula (I), where E is oxygen or sulphur; A is CR3 or N where R3 is hydrogen or hydrocarbyl; D completes a 5 or 6-membered non-aromatic heterocyclic ring which optionally contains additional heteroatoms selected from oxyge...
|
WO/1994/012181A1 |
Novel fibrinogen receptor antagonists of the formula: X-Y-Z-Aryl-A-B are provided in which the claimed compounds exhibit fibrinogen receptor antagonist activity, inhibit platelet aggregation and are therefore useful in modulating thrombu...
|
WO/1994/012461A1 |
This invention relates to 4-substituted catechol diether compounds which are selective inhibitors of phosphodiesterase (PDE) type IV. The compounds of the present invention are useful in inhibiting PDEIV and in the treatment of AIDS, ast...
|
WO/1994/011359A1 |
Processes for preparing 2,4-oxazolidinediones having formula (I) wherein: R1 is phenyl optionally substituted with 1-2 halogen; or 4-phenoxy, 4-(1-phenethyloxy) or 4-benzyloxy each optionally substituted with R2 on the phenyl ring; and R...
|
WO/1994/011340A1 |
A compound representd by general formula (I), a salt thereof, and a pest control agent, wherein: X represents halogen, alkyl, alkoxy, cycloalkyloxy, alkylsulfonyloxy, alkylthio or alkylsulfonyl; R1 represents hydrogen or alkyl; R2 repres...
|
WO/1994/011278A1 |
A container (1) is disclosed for collecting, composting or fermenting organic waste produced in households, small industries or the like. A venting hole (2) is arranged in the upper area of the collecting container and a biofilter (3) is...
|
WO/1994/011358A1 |
Described are sulphonyl urea compounds of the general formula I in which R1 is a methyl or ethyl group; R2 is C1-C3 alkoxycarbonyl, a C1-C2 alkyl group with 1 to 5 fluorine atoms, methylsulphonyl, dimethylaminosulphonyl, thiomethyl, meth...
|
WO/1994/011364A1 |
A process for preparing (+)-6-[(4-chlorophenyl)(1H_-1,2,4-triazol-1-yl)methyl]-1-met
hyl-1H_-benzotriazole comprising the resolution of (U)-6-[(4-chlorophenyl-hydrazinomethyl)-1-methyl-1H_-benzotr
iazole and converting the appropriate en...
|
WO/1994/011352A1 |
The invention relates to the use of partly novel substituted benzimidazoles of general formula (I) where X1, X2, X3 and X4 are mutually independently hydrogen, halogen, cyano, nitro, possibly substituted alkyl, alkoxy, alkylthio, alkylsu...
|
WO/1994/010164A1 |
The present invention is concerned with novel quinoline derivatives having anti-Helicobacter activity of formula (I), the pharmaceutically acceptable acid addition salts therof, the stereochemically isomeric forms thereof, the quaternize...
|
WO/1994/010154A1 |
Described are compounds of the formula (I) in which R1 to R4, W, X, Y and Z are as defined in claim 1. Such compounds are suitable for use in the control of weeds in crops. Intermediates of the formulae (II) and (III) may be used to prep...
|
WO/1994/010142A1 |
Substituted azetidinones of general formula (I) which have been found to be potent elastase inhibitors and thereby useful anti-inflammatory and antidegenerative agents, wherein: R4 is (a) or (b) where Rx is carboxy C1-6alkyl, benzyloxyca...
|
WO/1994/010165A1 |
Compounds of formula (I) wherein m is 2, 3 or 4; n is 0, 1 or 2 when m is 2 or 3, and n is 0 or 1 when m is 4; X represents O or S; R1 represents phenyl optionally substituted by 1, 2 or 3 groups selected from C1-6alkyl, C2-6alkenyl, C2-...
|
WO/1994/008973A1 |
A compound represented by general formula (I), wherein R1 represents imidazolyl, triazolyl or tetrazolyl each of which may be substituted by methyl and/or ethyl. R2 represents naphthyl, phenanthryl or anthryl each of which may be substit...
|
WO/1994/008582A1 |
A benzazepine compound represented by formulae (I) or (II) or a salt thereof, and a vasopressin antagonist or an oxytocin antagonist containing the above compound as the active ingredient.
|
WO/1994/008943A1 |
A 2-amino-1,3-propanediol compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, and an immunosuppressant containing the same as the active ingredient. In said formula R represents optionally substitut...
|
WO/1994/008972A1 |
The use of oligomeric imidazolium, pyrazolium and triazolium salts of formula (I) as swimming pool sanitizers having improved compatibility with chlorine. Bisimidazolium salts are preferred.
|
WO/1994/008978A1 |
Compounds having the structural formula (I), wherein R can be the same or different and is halogen, hydrogen, C1-C8 alkyl, C1-C8 haloalkyl, C3-C6 cycloalkyl, C7-C9 aralkyl, phenyl, nitro, C1-C6 alkoxy, C1-C6 alkylthio, C1-C6 alkylsulfiny...
|